Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
Titel:
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
Auteur:
Vermorken, J.B. Peyrade, F. Krauss, J. Mesía, R. Remenar, E. Gauler, T.C. Keilholz, U. Delord, J.P. Schafhausen, P. Erfán, J. Brümmendorf, T.H. Iglesias, L. Bethe, U. Hicking, C. Clement, P.M.